INTERVET GmbH
ATBRA.158266-000
Firmensitz
Siemensstraße 107 ident Richard-Neutra
1210 Wien
Vienna
Österreich
Kontakt
Geschäftsführung
Alexander Wirth
Member of the Supervisory Board
Seit 22. Juni 2022
Chair of the y Board Bernhard Sauer
Supervisor
Seit 22. Juni 2022
David Schröckenfuchs
Member of the Supervisory Board
Seit 22. Juni 2022
Deputy Chair of the y Board Gabriele Schallegger
Supervisor
Seit 22. Juni 2022
Henriette Echternach
Member of the Supervisory Board
Seit 15. April 2025
Katharina Kostecki
Managing Director
Seit 30. September 2024
Michael Schmidt
Managing Director
Seit 7. April 2025
Michel Deinum
Managing Director
Seit 15. September 2023
Allen HarbergEhemalig
Managing Director
9. Januar 2013 – 13. August 2019
Alphons VerhaegenEhemalig
Managing Director
1. August 2016 – 26. Oktober 2022
Henriëtte Jeanne van RijssenEhemalig
Managing Director
28. Juni 2019 – 7. Oktober 2023
Jean-Christophe ClotucheEhemalig
Managing Director
10. Februar 2022 – 15. April 2025
Klaus KriebitzschEhemalig
Managing Director
25. Juli 2012 – 26. August 2016
Michael SchmidtEhemalig
Member of the Supervisory Board
22. Juni 2022 – 7. April 2025
Michael WeberEhemalig
Managing Director
5. Oktober 2012 – 22. Mai 2021
Michael WeberEhemalig
Managing Director
3. Oktober 2022 – 3. August 2024
Finanzen
| Jahr | Umsatz | Gewinn | Bilanzsumme | Eigenkapitalquote |
|---|---|---|---|---|
| 2024 | 227.842.153 € | 11.222.105 € | 378.995.992 € | 66.3% |
| 2023 | 229.467.301 € | 10.096.580 € | 343.455.358 € | 54.1% |
| 2022 | 213.476.000 € | 11.131.000 € | 299.229.000 € | 62.1% |
Branche
NACE 21.20Herstellung von pharmazeutischen Spezialitäten und sonstigen pharmazeutischen ErzeugnissenISIC 2100Manufacture of pharmaceuticals, medicinal chemical and botanical productsNAICS 325199Basic Chemical ManufacturingNAICS 325411Pharmaceutical and Medicine ManufacturingNAICS 325412Pharmaceutical and Medicine ManufacturingNAICS 325413Pharmaceutical and Medicine ManufacturingNAICS 325414Pharmaceutical and Medicine ManufacturingNAICS 339113Medical Equipment and Supplies ManufacturingUKSIC 21.20Manufacture of pharmaceutical preparationsNACE2025 21.20Herstellung von pharmazeutischen Spezialitäten und sonstigen pharmazeutischen Erzeugnissen
Rohdaten
{
"id": "12ea54e4-4def-48da-85f4-192474707dbe",
"euId": "ATBRA.158266-000",
"name": "INTERVET GmbH",
"legalForm": "GmbH",
"status": "active",
"foundationDate": "1997-05-15T00:00:00",
"vatId": null,
"hq": {
"line2": null,
"street": "Siemensstraße 107 ident Richard-Neutra",
"city": "Wien",
"zipCode": "1210",
"state": "Vienna",
"country": "AT",
"latitude": 48.2770352,
"longitude": 16.404805
},
"contactData": {
"emails": [
"info.austria@msd.com"
],
"phones": [],
"websites": [
"https://msd-tiergesundheit.at/"
],
"faxes": []
},
"managers": [
{
"name": "Alexander Wirth",
"position": "Member of the Supervisory Board",
"startDate": "2022-06-22T00:00:00",
"endDate": null
},
{
"name": "Allen Harberg",
"position": "Managing Director",
"startDate": "2013-01-09T00:00:00",
"endDate": "2019-08-13T00:00:00"
},
{
"name": "Alphons Verhaegen",
"position": "Managing Director",
"startDate": "2016-08-01T00:00:00",
"endDate": "2022-10-26T00:00:00"
},
{
"name": "Chair of the y Board Bernhard Sauer",
"position": "Supervisor",
"startDate": "2022-06-22T00:00:00",
"endDate": null
},
{
"name": "David Schröckenfuchs",
"position": "Member of the Supervisory Board",
"startDate": "2022-06-22T00:00:00",
"endDate": null
},
{
"name": "Deputy Chair of the y Board Gabriele Schallegger",
"position": "Supervisor",
"startDate": "2022-06-22T00:00:00",
"endDate": null
},
{
"name": "Henriette Echternach",
"position": "Member of the Supervisory Board",
"startDate": "2025-04-15T00:00:00",
"endDate": null
},
{
"name": "Henriëtte Jeanne van Rijssen",
"position": "Managing Director",
"startDate": "2019-06-28T00:00:00",
"endDate": "2023-10-07T00:00:00"
},
{
"name": "Jean-Christophe Clotuche",
"position": "Managing Director",
"startDate": "2022-02-10T00:00:00",
"endDate": "2025-04-15T00:00:00"
},
{
"name": "Katharina Kostecki",
"position": "Managing Director",
"startDate": "2024-09-30T00:00:00",
"endDate": null
},
{
"name": "Klaus Kriebitzsch",
"position": "Managing Director",
"startDate": "2012-07-25T00:00:00",
"endDate": "2016-08-26T00:00:00"
},
{
"name": "Michael Schmidt",
"position": "Member of the Supervisory Board",
"startDate": "2022-06-22T00:00:00",
"endDate": "2025-04-07T00:00:00"
},
{
"name": "Michael Schmidt",
"position": "Managing Director",
"startDate": "2025-04-07T00:00:00",
"endDate": null
},
{
"name": "Michael Weber",
"position": "Managing Director",
"startDate": "2012-10-05T00:00:00",
"endDate": "2021-05-22T00:00:00"
},
{
"name": "Michael Weber",
"position": "Managing Director",
"startDate": "2022-10-03T00:00:00",
"endDate": "2024-08-03T00:00:00"
},
{
"name": "Michel Deinum",
"position": "Managing Director",
"startDate": "2023-09-15T00:00:00",
"endDate": null
}
],
"industry": {
"isic": [
"2100"
],
"nace": [
"21.20"
],
"nace2025": [
"21.20"
],
"naics": [
"325199",
"325411",
"325412",
"325413",
"325414",
"339113"
],
"uksic": [
"21.20"
],
"wz": []
},
"financials": [
{
"year": 2022,
"currency": "EUR",
"capital": 1800000,
"capitalIsEstimate": false,
"balanceTotal": 299229000,
"balanceTotalIsEstimate": false,
"earnings": 11131000,
"earningsIsEstimate": false,
"earningsCagr": 0,
"earningsCagrIsEstimate": false,
"revenue": 213476000,
"revenueIsEstimate": false,
"revenueCagr": 0,
"revenueCagrIsEstimate": false,
"returnOnSales": 5.214169274297813,
"returnOnSalesIsEstimate": false,
"equity": 185859000,
"equityIsEstimate": false,
"equityRatio": 62.112629457706305,
"equityRatioIsEstimate": false,
"cash": 0,
"cashIsEstimate": false,
"receivables": 3035000,
"receivablesIsEstimate": false,
"liabilities": 17491000,
"liabilitiesIsEstimate": false
},
{
"year": 2023,
"currency": "EUR",
"capital": 1800000,
"capitalIsEstimate": false,
"balanceTotal": 343455358.11,
"balanceTotalIsEstimate": false,
"earnings": 10096579.88,
"earningsIsEstimate": false,
"earningsCagr": -9.293146348037007,
"earningsCagrIsEstimate": false,
"revenue": 229467301.13,
"revenueIsEstimate": false,
"revenueCagr": 7.490912856714571,
"revenueCagrIsEstimate": false,
"returnOnSales": 4.400008118925838,
"returnOnSalesIsEstimate": false,
"equity": 185955757.59,
"equityIsEstimate": false,
"equityRatio": 54.142628204519994,
"equityRatioIsEstimate": false,
"cash": 0,
"cashIsEstimate": false,
"receivables": 3294094.09,
"receivablesIsEstimate": false,
"liabilities": 36713118.15,
"liabilitiesIsEstimate": false
},
{
"year": 2024,
"currency": "EUR",
"capital": 1800000,
"capitalIsEstimate": false,
"balanceTotal": 378995992.24,
"balanceTotalIsEstimate": false,
"earnings": 11222105.06,
"earningsIsEstimate": false,
"earningsCagr": 0.408406251656368,
"earningsCagrIsEstimate": false,
"revenue": 227842153.37,
"revenueIsEstimate": false,
"revenueCagr": 3.3100353061036314,
"revenueCagrIsEstimate": false,
"returnOnSales": 4.925385796269259,
"returnOnSalesIsEstimate": false,
"equity": 251177862.65,
"equityIsEstimate": false,
"equityRatio": 66.27454321230424,
"equityRatioIsEstimate": false,
"cash": 0,
"cashIsEstimate": false,
"receivables": 2943935.09,
"receivablesIsEstimate": false,
"liabilities": 28033852.96,
"liabilitiesIsEstimate": false
}
]
}